FSIP2 and nonpapillary renal cell carcinoma: In this study, we evaluated FSIP2 expression in 85 patients with clear cell RCC (ccRCC), analyzed the association between FSIP2 expression and clinicopathological characteristics of patients, and correlated expression with patient survival outcomes.